Difference between revisions of "Part:BBa K1933100"
(→‎Characterization)
Line 15: Line 15:
  
 
==Characterization==
 
==Characterization==
−
[[file:T--Kyoto--Membrane protein.PNG|400px|thumb|right|'''Figure 1''': Western blotting of membrane fraction]]
+
[[file:T--Kyoto--Membrane protein.PNG|400px|thumb|right|'''Figure 1''': Western blotting analysis of membrane fraction]]
 
<br>''' Western blotting of membrane fraction '''
 
<br>''' Western blotting of membrane fraction '''
 
<br>Anti-6His western blotting analysis of E. coli displaying BclA or INPNC-6xHis-fused scFv, CBDcex, and CBDclos.
 
<br>Anti-6His western blotting analysis of E. coli displaying BclA or INPNC-6xHis-fused scFv, CBDcex, and CBDclos.

Revision as of 08:03, 14 October 2016


constitutive expression of CBDcex fused to INPNC with 6xHis tag

CBDcex fused to INPNC with 6xHis tag is one of a series of surface expressing fusion proteins that make up biodevice that aims to be therapeutic solution against norovirus infections. This protein in particular is a cellulose binding protein(CBDcex) fused to surface expression anchoring domain(INPNC), connected by a 6xHis tag to be easily identified by Western blotting. For more information, please visit [http://2016.igem.org/Team:Kyoto our wiki].

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 7
    Illegal NheI site found at 30
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 1012
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 132
    Illegal NgoMIV site found at 465
    Illegal AgeI site found at 883
  • 1000
    COMPATIBLE WITH RFC[1000]


Usage

Characterization

Figure 1: Western blotting analysis of membrane fraction


Western blotting of membrane fraction
Anti-6His western blotting analysis of E. coli displaying BclA or INPNC-6xHis-fused scFv, CBDcex, and CBDclos.
Lane M, molecular weight size markers; Lanes 1, E. coli which didn’t express His-tagged proteins. (BBa_E1010) We used this parts as a negative control; Lanes 2, 4, and 6, E. coli harboring INPNC-6His fusion proteins, in the order of INPNC-6His-CBDclos(~47 kDa), INPNC-6His-CBDcex(~47 kDa), and INPNC-6His-scFv(~63 kDa); Lanes 3, 5, and 7, E. coli harboring BclA-6His fusion proteins, in the order of BclA-6His-CBDclos(~17 kDa), BclA-6His-CBDcex(~17 kDa), and BclA-6His-scFv(~63 kDa); Lanes 8, and 9, E. coli harboring Lpp-OmpA-scFv-6His(~43 kDa). (BBa_875004) We used this parts as a positive control.; Lanes 1~7, outer membrane fraction.; Lane 8, and 9, total proteins.


Figure 1: Western blotting of whole cell

<Whole cell Western Blot>
Anti-6His western blotting analysis of E. coli displaying BclA or INPNC-6His-fused scFv, CBDcex, and CBDclos. Lane M, molecular weight size markers; Lanes 1, E. coli doesn’t express histagged proteins. (BBa_K165002) We used this parts as a negative control; Lanes 2, 4, and 6, E. coli harboring BclA-6His fusion proteins, in the order of BclA-6His-CBDclos(~17 kDa), BclA-6His-CBDcex(~17 kDa), and BclA-6His-scFv(~33 kDa); Lanes 3, 5, and 7, E. coli harboring INPNC-6His fusion proteins, in the order of INPNC-6His-CBDclos(~47 kDa), INPNC-6His-CBDcex(~47 kDa), and INPNC-6His-scFv(~63 kDa); Lanes 8, E. coli harboring Lpp-OmpA-scFv-6His(~ 43kDa). (BBa_875004) We used this parts as a positive control.; Lanes 1~8, total proteins.

Reference

Judging